Sepsis Clinical Pathway — Emergency Department, Inpatient and PICU
Sepsis Clinical Pathway — Emergency Department, Inpatient and PICU
Fluid Refractory Shock and Catecholamine Resistant Shock
Fluid Refractory Shock
Shock persists despite 40-60 mL/kg fluid resuscitation
- Assess Cardiac Function
- Obtain bedside cardiac ultrasound or echocardiogram to assess cardiac function
- If ultrasound unable to be completed, do NOT delay vasoactive medication
- Consider serial assessments of cardiac function if increasing SVR with vasoactive medications
- Cardiology consult if question of systolic dysfunction on bedside echocardiogram
Initiate Vasoactive Therapy
Vasoactive therapies can be initiated peripherally.
Consider arterial line, CVL, Foley for patients on vasoactive infusion for > 1 hour
DO NOT DELAY initiation of vasoactive therapy to obtain cardiac function assessment.
- If imaging not available, assume decreased function in the setting of fluid refractive shock.
- Initiate direct acting catecholamine (epinephrine or norepinephrine) per provider discretion.
First Line Recommendations
Vasoactive | Dose | Considerations | Cautions |
---|---|---|---|
Epinephrine | Starting dose: 0.05 mcg/kg/min |
|
Consider patient physiology, clinical preference and local systems factors when selecting first line catecholamine. |
Norepinephrine | Starting dose: 0.05 mcg/kg/min |
|
|
Dopamine | 5 mcg/kg/min | May substitute as the first line vasoactive if epinephrine/norepinephrine not readily available |
Catecholamine Resistant Shock
Vasoactive | Dose | Considerations | Cautions |
---|---|---|---|
Milrinone | 0.3 mcg/kg/min | Consider if persistent hypoperfusion and cardiac dysfunction despite other agents | May cause hypotension |
Dobutamine | 5 mcg/kg/min | Consider if persistent hypoperfusion and cardiac dysfunction despite other agents | |
Vasopressin | 12 milli-units/kg/hr | Consider if requiring high-dose catecholamines |